Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug;57(8):2066-73.
doi: 10.2337/db07-0763. Epub 2008 Apr 28.

siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle

Reginald L Austin  1 , Anna Rune, Karim Bouzakri, Juleen R Zierath, Anna Krook
Affiliations

siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle

Reginald L Austin et al. Diabetes. 2008 Aug.

Abstract

Objective: Proinflammatory cytokines contribute to systemic low-grade inflammation and insulin resistance. Tumor necrosis factor (TNF)-alpha impedes insulin signaling in insulin target tissues. We determined the role of inhibitor of nuclear factor-kappaB kinase (IKK)beta in TNF-alpha-induced impairments in insulin signaling and glucose metabolism in skeletal muscle.

Research design and methods: Small interfering RNA (siRNA) was used to silence IKKbeta gene expression in primary human skeletal muscle myotubes from nondiabetic subjects. siRNA gene silencing reduced IKKbeta protein expression 73% (P < 0.05). Myotubes were incubated in the absence or presence of insulin and/or TNF-alpha, and effects of IKKbeta silencing on insulin signaling and glucose metabolism were determined.

Results: Insulin increased glucose uptake 1.7-fold (P < 0.05) and glucose incorporation into glycogen 3.8-fold (P < 0.05) in myotubes from nondiabetic subjects. TNF-alpha exposure fully impaired insulin-mediated glucose uptake and metabolism. IKKbeta siRNA protected against TNF-alpha-induced impairments in glucose metabolism, since insulin-induced increases in glucose uptake (1.5-fold; P < 0.05) and glycogen synthesis (3.5-fold; P < 0.05) were restored. Conversely, TNF-alpha-induced increases in insulin receptor substrate-1 serine phosphorylation (Ser(312)), Jun NH(2)-terminal kinase phosphorylation, and extracellular signal-related kinase-1/2 mitogen-activated protein kinase (MAPK) phosphorylation were unaltered by siRNA-mediated IKKbeta reduction. siRNA-mediated IKKbeta reduction prevented TNF-alpha-induced insulin resistance on Akt Ser(473) and Thr(308) phosphorylation and phosphorylation of the 160-kDa Akt substrate AS160. IKKbeta silencing had no effect on cell differentiation. Finally, mRNA expression of GLUT1 or GLUT4 and protein expression of MAPK kinase kinase kinase isoform 4 (MAP4K4) was unaltered by IKKbeta siRNA.

Conclusions: IKKbeta silencing prevents TNF-alpha-induced impairments in insulin action on Akt phosphorylation and glucose uptake and metabolism in human skeletal muscle.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Protein expression of IKKβ and IκBα. A: Protein expression of IKKβ was unaltered in cells exposed to a scrambled siRNA sequence, a 2-h incubation with TNF-α (lanes 1–3). siRNA against IKKβ reduced protein expression by 73% (lanes 4 and 5). Glyceraldehyde-3-phosphate dehydrogenase (GADPH) expression was determined to control for equal loading. B: IκBα was measured after siRNA-mediated depletion of IKKβ. Results are means ± SE. *P < 0.05 vs. transfected scrambled siRNA (Scr) control (n = 4).
FIG. 2.
FIG. 2.
Myotube growth. A: Morphological appearance of human skeletal muscle myotube formation after introduction of scrambled siRNA or siRNA against IKKβ. Photomicrographs are shown at 10× magnification for myotubes at day 6 of differentiation (4 days after introduction of siRNA). Results are from two separate experiments. B: Representative immunoblot showing the differentiation marker desmin.
FIG. 3.
FIG. 3.
Effect of siRNA-mediated silencing of IKKβ on glucose uptake and glycogen synthesis. Glucose uptake (A) and glycogen synthesis (B) were measured in differentiated primary skeletal muscle myotubes under basal conditions (□) and after insulin stimulation (▪). Results are means ± SE. *P < 0.05 vs. respective basal cells. †P < 0.05 vs. TNF-α–and insulin-stimulated untransfected cells (n = 4).
FIG. 4.
FIG. 4.
Akt Ser473 and Thr308 phosphorylation. Representative immunoblot showing Akt Ser473 (A) and Akt Thr308 (B) phosphorylation in response to insulin and TNF-α. C: Total Akt protein expression. Graphs are summarized data (mean ± SE). *P < 0.05% vs. untransfected control cells. †P < 0.05 vs. TNF-α–stimulated untransfected cells (n = 9).
FIG. 5.
FIG. 5.
GSK-3β and AS160 phosphorylation. Representative immunoblot showing pGSK3β Ser9 (A) and Akt substrate AS160 (B) phosphorylation in response to insulin or TNF-α under basal conditions (□) and after insulin stimulation (▪). Graphs are summarized data (mean ± SE). *P < 0.05 vs. respective basal. †P < 0.05 vs. TNF-α–stimulated untransfected cells. #P < 0.05 vs. control basal (GSK3β, n = 3; AS160, n = 4).
FIG. 6.
FIG. 6.
Effect of siRNA-mediated silencing of IKKβ on ERK1/2 MAPK phosphorylation. A: Representative immunoblot of ERK1/2 MAPK phosphorylation. B: Total ERK-2 protein expression. C: Summarized results for ERK1/2 MAPK under basal (□) or insulin-stimulated (▪) conditions. (n = 5). D: Glycogen synthesis was measured in differentiated primary skeletal muscle myotubes following 1 h of exposure to 50 μmol/l PD98059. Results are means ± SE from experiment carried out in triplicate. *P < 0.05 vs. respective basal. #P < 0.05 vs. control basal.
FIG. 7.
FIG. 7.
Effect of siRNA-mediated silencing of IKKβ on JNK phosphorylation. A: Representative immunoblot showing p54/p46 JNK phosphorylation. B: Summarized results for p54 and p46 JNK phosphorylation under basal (□) or insulin-stimulated (▪) conditions. Results are mean ± SE. *P < 0.05 vs. respective basal. #P < 0.05 vs. control basal (n = 3).
FIG. 8.
FIG. 8.
Effect of siRNA-mediated silencing of IKKβ on IRS-1 Ser312 phosphorylation. Representative immunoblot showing IRS-1 migration on SDS-PAGE (A) or IRS-1 Ser312 phosphorylation (B). IRS-1 Ser312 phosphorylation results under basal (□) and insulin-stimulated (▪) conditions are reported as means ± SE percent relative to basal untransfected controls. Arrow highlights mobility shift (A) (n = 4).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK: Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54: 2939–2945, 2005 - PubMed
    1. Yin MJ, Yamamoto Y, Gaynor RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396: 77–80, 1998 - PubMed
    1. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE: Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293: 1673–1677, 2001 - PubMed
    1. Ruotsalainen E, Salmenniemi U, Vauhkonen I, Pihlajamaki J, Punnonen K, Kainulainen S, Laakso M: Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects. Diabetes Care 29: 2714–2720, 2006 - PubMed
    1. Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 116: 1793–1801, 2006 - PMC - PubMed

Publication types

MeSH terms